• 1
    Parsons JK. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep 2010; 5: 2128
  • 2
    Platz EA, Kawachi I, Rimm EB, Willett WC, Giovannucci E. Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study. J Urol 2000; 163: 4905
  • 3
    Jin B, Turner L, Zhou Z, Zhou EL, Handelsman DJ. Ethnicity and migration as determinants of human prostate size. J Clin Endocrinol Metab 1999; 84: 36139
  • 4
    Kristal AR, Arnold KB, Schenk JM et al. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol 2008; 167: 92534
  • 5
    Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol 2007; 178: 395401
  • 6
    Bravi F, Bosetti C, Dal Maso L et al. Food groups and risk of benign prostatic hyperplasia. Urology 2006; 67: 739
  • 7
    Untergasser G, Madersbacher S, Berger P. Benign prostatic hyperplasia: age-related tissue-remodeling. Exp Gerontol 2005; 40: 1218
  • 8
    Alcaraz A, Hammerer P, Tubaro A, Schroder FH, Castro R. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Eur Urol 2009; 55: 86473
  • 9
    Steinbrecher A, Meplan C, Hesketh J et al. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol Biomarkers Prev 2010; 19: 295868
  • 10
    Steinbrecher A, Nimptsch K, Husing A, Rohrmann S, Linseisen J. Dietary glucosinolate intake and risk of prostate cancer in the EPIC-Heidelberg cohort study. Int J Cancer 2009; 125: 217986
  • 11
    Steinbrecher A, Rohrmann S, Timofeeva M, Risch A, Jansen E, Linseisen J. Dietary glucosinolate intake, polymorphisms in selected biotransformation enzymes, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2010; 19: 13543
  • 12
    Dragin N, Smani M, Arnaud-Dabernat S et al. Acute oxidative stress is associated with cell proliferation in the mouse liver. FEBS Lett 2006; 580: 384552
  • 13
    Muecke R, Klotz T, Giedl J et al. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH. Acta Oncol 2009; 48: 4526
  • 14
    Dinkova-Kostova AT, Talalay P. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 2008; 52 (Suppl. 1): S12838
  • 15
    Gromadzinska J, Reszka E, Bruzelius K, Wasowicz W, Akesson B. Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements. Eur J Nutr 2008; 47 (Suppl. 2): 2950
  • 16
    Peters U, Takata Y. Selenium and the prevention of prostate and colorectal cancer. Mol Nutr Food Res 2008; 52: 126172
  • 17
    Alfthan G, Xu GL, Tan WH et al. Selenium supplementation of children in a selenium-deficient area in China: blood selenium levels and glutathione peroxidase activities. Biol Trace Elem Res 2000; 73: 11325
  • 18
    Persson-Moschos M, Alfthan G, Akesson B. Plasma selenoprotein P levels of healthy males in different selenium status after oral supplementation with different forms of selenium. Eur J Clin Nutr 1998; 52: 3637
  • 19
    Hayes JD, Kelleher MO, Eggleston IM. The cancer chemopreventive actions of phytochemicals derived from glucosinolates. Eur J Nutr 2008; 47 (Suppl. 2): 7388
  • 20
    Lampe JW, Chen C, Li S et al. Modulation of human glutathione S-transferases by botanically defined vegetable diets. Cancer Epidemiol Biomarkers Prev 2000; 9: 78793
  • 21
    Hofmann T, Kuhnert A, Schubert A et al. Modulation of detoxification enzymes by watercress: in vitro and in vivo investigations in human peripheral blood cells. Eur J Nutr 2009; 48: 48391
  • 22
    Andonova IE, Justenhoven C, Winter S et al. No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer risk. Breast Cancer Res Treat 2010; 121: 497502
  • 23
    Ambrosini GL, de Klerk NH, Mackerras D, Leavy J, Fritschi L. Dietary patterns and surgically treated benign prostatic hyperplasia: a case control study in Western Australia. BJU Int 2008; 101: 85360
  • 24
    Rohrmann S, Smit E, Giovannucci E, Platz EA. Association between serum concentrations of micronutrients and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey. Urology 2004; 64: 5049
  • 25
    Zachara BA, Szewczyk-Golec K, Tyloch J et al. Blood and tissue selenium concentrations and glutathione peroxidase activities in patients with prostate cancer and benign prostate hyperplasia. Neoplasma 2005; 52: 24854
  • 26
    Boeing H, Korfmann A, Bergmann MM. Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab 1999; 43: 20515
  • 27
    Kroke A, Bergmann MM, Lotze G, Jeckel A, Klipstein-Grobusch K, Boeing H. Measures of quality control in the German component of the EPIC study. European Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab 1999; 43: 21624
  • 28
    Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 15869
  • 29
    Sieniawska C, Mensikov R, Delves H. Determination of total selenium in serum, whole blood and erythrocytes by ICP-MS. J Anal Atomic Spectrom 1999; 14: 10912
  • 30
    Hollenbach B, Morgenthaler NG, Struck J et al. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol 2008; 22: 2432
  • 31
    Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997; 26 (Suppl. 1): S5970
  • 32
    Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J. Reproducibility and relative validity of energy and macronutrient intake of a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997; 26 (Suppl. 1): S7181
  • 33
    Steinbrecher A, Linseisen J. Dietary intake of individual glucosinolates in participants of the EPIC-Heidelberg cohort study. Ann Nutr Metab 2009; 54: 8796
  • 34
    Willett W. Nutritional Epidemiology, 1st edn. New York: Oxford University Press, 1998
  • 35
    Aydin A, Arsova-Sarafinovska Z, Sayal A et al. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. Clin Biochem 2006; 39: 1769
  • 36
    Parsons JK. Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms. Curr Opin Urol 2011; 21: 14
  • 37
    Willis MS, Wians FH. The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances. Clin Chim Acta 2003; 330: 5783
  • 38
    Yang G, Zhu L. Human selenium requirements in China. In Combs G, Levander O, Spallholz J, Oldfield J eds, Selenium in Biology and Medicine, New York: AVI, 1987: 589607
  • 39
    Hill KE, Xia Y, Akesson B, Boeglin ME, Burk RF. Selenoprotein P concentration in plasma is an index of selenium status in selenium-deficient and selenium-supplemented Chinese subjects. J Nutr 1996; 126: 13845
  • 40
    Standing Committe on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press, 2000
  • 41
    Xia Y, Hill KE, Li P et al. Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled, double-blind study of selenomethionine supplementation in selenium-deficient Chinese subjects. Am J Clin Nutr 2010; 92: 52531
  • 42
    Rayman MP. The importance of selenium to human health. Lancet 2000; 356: 23341